Related Experiment Video
Updated: Dec 29, 2025
06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
13.3K
[Tumor producing amylase].
Takanori Moriyama1, Tatsuo Tozawa, Kazuhiko Matsuno
1Department of Laboratory Technology, College of Medical Technology, Hokkaido University, Sapporo 060-0812.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 9, 2002
Summary
Researchers identified sialyl salivary-type amylase in cancer patients
Area of Science:
- Biochemistry
- Oncology
- Clinical Chemistry
Context:
- Tumor-producing amylase typically presents as salivary-type amylase.
- Abnormal amylase isoforms in serum can indicate malignancy.
- Distinguishing cancer-associated amylase from normal variants is crucial for diagnostics.
Purpose:
- To investigate the presence and characteristics of sialyl salivary-type amylase in cancer patients.
- To differentiate this abnormal amylase from standard salivary amylase.
- To explore its potential as a biomarker for specific malignancies.
Summary:
- Sialyl salivary-type amylase, exhibiting abnormal anodic migration, was detected in the sera of patients with multiple myeloma and ovarian cancer using isoamylase electrophoretic analysis.
- These abnormal isoamylase bands migrated faster than the standard salivary isoamylase (S2) and showed increased staining intensity.
- Gel permeation chromatography facilitated separation from normal isoamylases, and neuraminidase treatment confirmed sensitivity, with reactivity to anti-human salivary monoclonal antibody.
Impact:
- This finding may lead to novel diagnostic markers for multiple myeloma and ovarian cancer.
- Understanding aberrant glycosylation patterns in amylase could offer insights into cancer biology.
- The characterized sialyl salivary-type amylase could serve as a target for future therapeutic strategies.
